Insufficient scRNA-seq data for expression of ULBP1 at single-cell level.
Insufficient scRNA-seq data for expression of ULBP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 266.44 | 574 / 578 | 61% | 3.35 | 710 / 1155 |
thymus | 63% | 37.94 | 413 / 653 | 52% | 2.87 | 317 / 605 |
esophagus | 11% | 10.14 | 161 / 1445 | 69% | 3.24 | 127 / 183 |
kidney | 58% | 34.12 | 52 / 89 | 12% | 0.31 | 106 / 901 |
tonsil | 0% | 0 | 0 / 0 | 67% | 2.50 | 30 / 45 |
adrenal gland | 21% | 10.33 | 55 / 258 | 45% | 1.70 | 103 / 230 |
uterus | 7% | 3.24 | 12 / 170 | 56% | 3.14 | 259 / 459 |
breast | 17% | 9.49 | 79 / 459 | 38% | 1.75 | 428 / 1118 |
heart | 54% | 27.55 | 467 / 861 | 0% | 0 | 0 / 0 |
brain | 30% | 107.32 | 780 / 2642 | 22% | 0.81 | 153 / 705 |
skin | 43% | 376.16 | 776 / 1809 | 8% | 0.30 | 39 / 472 |
bladder | 10% | 5.29 | 2 / 21 | 35% | 1.15 | 177 / 504 |
intestine | 8% | 3.28 | 74 / 966 | 35% | 0.87 | 184 / 527 |
stomach | 7% | 4.11 | 26 / 359 | 29% | 0.84 | 83 / 286 |
pancreas | 7% | 3.17 | 23 / 328 | 26% | 0.60 | 46 / 178 |
adipose | 28% | 16.44 | 336 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 21% | 0.45 | 17 / 80 |
liver | 8% | 4.44 | 18 / 226 | 12% | 0.36 | 49 / 406 |
prostate | 7% | 2.66 | 17 / 245 | 13% | 0.26 | 65 / 502 |
blood vessel | 17% | 6.82 | 221 / 1335 | 0% | 0 | 0 / 0 |
ovary | 5% | 1.88 | 9 / 180 | 10% | 0.23 | 41 / 430 |
peripheral blood | 13% | 5.40 | 117 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.14 | 3 / 29 |
muscle | 7% | 2.18 | 53 / 803 | 0% | 0 | 0 / 0 |
spleen | 4% | 3.60 | 9 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0006955 | Biological process | immune response |
GO_0030101 | Biological process | natural killer cell activation |
GO_0002476 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
GO_0002486 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0046703 | Molecular function | natural killer cell lectin-like receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0048018 | Molecular function | receptor ligand activity |
Gene name | ULBP1 |
Protein name | UL16-binding protein 1 (ALCAN-beta) (NKG2D ligand 1) (N2DL-1) (NKG2DL1) (Retinoic acid early transcript 1I) |
Synonyms | N2DL1 RAET1I |
Description | FUNCTION: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity. . |
Accessions | Q9BZM6 ENST00000229708.4 |